SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-22-315430
Filing Date
2022-12-30
Accepted
2022-12-30 16:11:40
Documents
4
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 PREM14A d418961dprem14a.htm PREM14A 2092499
2 EX-FILING FEES d418961dexfilingfees.htm EX-FILING FEES 16511
3 GRAPHIC g418961g06y90.jpg GRAPHIC 29387
4 GRAPHIC g418961g40h45.jpg GRAPHIC 50040
  Complete submission text file 0001193125-22-315430.txt   2219965
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-35238 | Film No.: 221502098
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences